Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

In Brief: Bioethics hearing

  • News

Executive Summary

Bioethics hearing: FDA Deputy Commissioner Mary Pendergast and NIH Director Harold Varmus to testify on bioethics and informed consent at May 8 hearing of Rep. Shays' (R-Conn.) House Government Reform/Human Resources Subcommittee. Other government witnesses will include William Raub of HHS and CDC Director David Satcher. Also scheduled to testify are Arthur Caplan, University of Pennsylvania; Peter Lurie, University of California; Benjamin Wilfond, University of Arizona; and Laurie Flynn, National Alliance for the Mentally Ill...

Table

View full table

Tags:
Latest Headlines

AI Used In Drug R&D Likely Exempt From Tough EU AI Rules, Says EFPIA

EU Parliament OKs New Rules On Use Of Patient Data In Research

Danes Advise Pharma Firms To Test Their Anti-Tamper Devices

Joint Clinical Assessments: EU Guidance On Evidence May Be Flexible For ATMPs And Single Arm Trials

See All
UsernamePublicRestriction

Register

PS030142

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By